Intrinsic Therapeutics is proud to announce that the US Veterans Administration (VA) has officially added the (Barricaid Implantation) HCPCS code C9757 to their 2021 national outpatient fee schedule – effective January 1, 2021.¹ The VA is the 2nd largest government-funded health insurance organization in the U.S. with approximately 9 million covered lives. The Barricaid, a […]
Read moreIn the News
A Level IA Expert Review and Meta-Analysis Provides Support for the Adoption of Barricaid in Well-Selected Patients Undergoing Lumbar Discectomy for Lumbar Disc Herniation
NewsThe importance of a cost-effective treatment option for patients with large annular defects is underscored by a recently published Level IA expert review and meta-analysis of four comparative studies (n=801 patients) including two randomized controlled trials involving more than 600 patients. In this review, the authors (L Miller, R Todd Allen, B Duhon, K Radcliff) […]
Read more
Surgeons and Spine Societies Increase Patient Access to Barricaid® for Discectomy Surgery Following Recent Coding Successes and Recognition in Updated Guidelines
Press ReleaseIntrinsic Therapeutics Offers Virtual and Hands-On Training Sessions as Elective Surgeries Resume – via PR Newswire WOBURN, Mass., June 2, 2020 – Intrinsic Therapeutics, Inc., a medical device company focused on delivering safe treatments to improve surgical efficacy, today announced growing enthusiasm among physicians for its Barricaid technology, which manages lumbar disc herniation. While elective […]
Read more
COVID-19 Company Update
Company Update“The measure of intelligence is the ability to change.” ― Albert Einstein. While this unprecedented time has forced us all to make changes and sacrifices, the Intrinsic team is using the time to learn and adopt innovative ways to educate and train the medical and patient communities on the impact Barricaid can have in managing lumbar […]
Read moreAnnular Closure a Key Topic in latest Int Journal of Spine Surgery
Barricaid and the topic of annular closure for herniated disc patients feature in two articles in the most recent issue by IJSS, the International Journal of Spine Surgery. This journal is the official publication of ISASS, the International Society for the Advancement of Spine Surgery. ISASS is among the largest societies of spine surgeons, and […]
Read more“Annular repair and the field of disc biology” named critical area for advancement, Becker’s Spine
This week, in a conversation with Becker’s Healthcare, Dr. Andrew Hecht (MD, Mt. Sinai Hospital, New York City) named “annular repair and the field of disc biology” one of the next big trends in spine. Barricaid is designed to close large annular holes, thereby reducing reherniation rates in patients at higher risk. Thank you, Dr. […]
Read moreRecap of a successful inaugural U.S. Disc Collective Meeting
Press ReleaseNew York NY, January 2020 – Intrinsic Therapeutics hosted its first U.S. Disc Collective Meeting on 16-17 January, 2020 in Manhattan, New York. 15 spine surgeons travelled to the East Coast in order to learn more about and exchange experiences on the topic of lumbar disc herniation. The program was themed around “A future of […]
Read moreBarricaid maker Intrinsic Therapeutics among top 20 private medtech companies
NewsThe Barricaid team is proud to be ranked among the top 20 private medtech companies to watch in 2020 by MDDI (Medical Device and Diagnostic Industry). To our mission, we stay committed to reducing needless suffering by ensuring Barricaid Annular Closure is accessible to patients and surgeons. Intrinsic Therapeutics’ Barricaid device is the only FDA […]
Read moreStudy in Spine: Annular Closure Device Good Option
NewsOn Tuesday, January 8th, 2019, Orthopedics This Week reports about a multicenter study from Northwestern University, The University of California-Davis, and the OLVG Hospital in Amsterdam, that has looked into costs associated with employing the Barricaid annular closure device for patients who are at high risk for recurrent herniation after a discectomy. Their work, “Cost-effectiveness of a bone-anchored annular […]
Read moreBarricaid superiority data presented at 25th Brussels international spine symposium
NewsThe Brussels International Spine Symposium (BISS) is globally recognized as one of the world leading, state-of-art annual meetings in Spine. Under the auspice of Drs. Marek Szpalski and Robert Gunzburg, the 25th anniversary meeting took place on 16-17 November 2018 reviewing the topic of Disc Herniation – Back to Basics: Controversies in diagnosis, management and costs. One […]
Read more